Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
Sturkenboom, M; Bahri, P; Chiucchiuini, A; Grove Krause, T; Hahné, S; Khromava, A; Kokki, M; Kramarz, P; Kurz, X; LARSON, HJ; De Lusignan, S; Mahy, P; Torcel-Pagnon, L; Titievsky, L; Bauchau, V; ADVANCE consortium,;
2019
Vaccine, (2019).38 Sup, 10.1016/j.vaccine.2019.07.081.
Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study.
Mosser, JF; Gagne-Maynard, W; Rao, PC; Osgood-Zimmerman, A; Fullman, N; Graetz, N; Burstein, R; Updike, RL; Liu, PY; Ray, SE; Earl, L; Deshpande, A; Casey, DC; Dwyer-Lindgren, L; Cromwell, EA; Pigott, DM; Shearer, FM; LARSON, HJ; Weiss, DJ; Bhatt, S; Gething, PW; Murray, CJ L; Lim, SS; Reiner, RC; Hay, SI;
2019
Lancet, (2019).393 10183 10.1016/S0140-6736(19)30226-0.
Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease.
Liu, D; Leung, K; JIT, M; Yu, H; Yang, J; Liao, Q; Liu, F; Zheng, Y; Wu, JT;
2019
Clinical microbiology and infection, (2019).26 3 10.1016/j.cmi.2019.06.029.
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.
CLARK, A; VAN ZANDVOORT, K; FLASCHE, S; SANDERSON, C; Bines, J; Tate, J; Parashar, U; JIT, M;
2019
LANCET INFECTIOUS DISEASES, (2019).19 7 10.1016/S1473-3099(19)30126-4.
Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines.
FLASCHE, S; WILDER-SMITH, A; Hombach, J; SMITH, PG;
2019
Wellcome open research, (2019).4, 10.12688/wellcomeopenres.15507.1.
Reply letter re: "Mass psychogenic illness following HPV immunization in Carmen de Bolivar, Colombia".
Simas, C; Munoz, N; Arregoces, L; LARSON, HJ;
2019
HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2019).15 5 10.1080/21645515.2019.1586031.
Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.
Esposito, S; Stefanelli, P; Fry, NK; Fedele, G; He, Q; PATERSON, P; Tan, T; Knuf, M; Rodrigo, C; Weil Olivier, C; Flanagan, KL; Hung, I; Lutsar, I; Edwards, K; O'Ryan, M; Principi, N; World Association of Infectious Diseases and Immun,;
2019
FRONTIERS IN IMMUNOLOGY, (2019).10 JUL 10.3389/fimmu.2019.01344.
Vaccination coverage and factors associated with routine childhood vaccination uptake in rural Vellore, southern India, 2017.
FRANCIS, MR; Nuorti, JP; Kompithra, RZ; LARSON, H; Balraj, V; Kang, G; Mohan, VR;
2019
Vaccine, (2019).37 23 10.1016/j.vaccine.2019.04.058.
Mathematical modelling of the epidemiological impact, budget impact and cost-effectiveness of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral Presentation].
WEERASURIYA, C; Harris, R; BOZZANI, F; Gomez, GB; WHITE, R;
2019
International Journal of Tuberculosis and Lung Disease, (2019).23 10
Strategies to improve maternal vaccination acceptance.
Wilson, R; PATERSON, P; LARSON, HJ;
2019
BMC PUBLIC HEALTH, (2019).19 1 10.1186/s12889-019-6655-y.